The prognostic value of 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography in patients with suspected residual or recurrent medullary thyroid carcinoma

Molecular Imaging and Biology

Volumn 12, Issue 5, 2010, Pages 547-553

  Bogsrud, Trond Velde ^a   Karantanis, Dimitrios ^b   Nathan, Mark A ^b   Mullan, Brian P ^b   Wiseman, Gregory A ^b   Kasperbauer, Jan L ^b   Reading, Carl C ^b   Björo, Trine ^a   Hay, Ian D ^b   Lowe, Val J ^b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b MAYO CLINIC   (United States)

Author keywords

2 deoxy 2 18F fluoro d glucose; FDG; Medullary thyroid carcinoma; PET; PET CT; Positron emission tomography

Indexed keywords

CALCITONIN; CARCINOEMBRYONIC ANTIGEN; FLUORODEOXYGLUCOSE F 18;

ADOLESCENT; ADULT; ARTICLE; ASPIRATION BIOPSY; CALCITONIN BLOOD LEVEL; CANCER GROWTH; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MALE; METASTASIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RECURRENT CANCER; RETROSPECTIVE STUDY; THYROID MEDULLARY CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, MEDULLARY; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RECURRENCE; THYROID NEOPLASMS;

EID: 78049336593     PISSN: 15361632     EISSN: 18602002     Source Type: Journal    
DOI: 10.1007/s11307-009-0276-2     Document Type: Article

References (25)

1. YN You V Lakhani SA Wells JF Moley 2006 Medullary thyroid cancer Surg Oncol Clin N Am 15 639 660 10.1016/j.soc.2006.05.008 16882502 (Pubitemid 44119212)
2. E Kebebew PHG Ituarte AE Siperstein Q-Y Duh OH Clark 2000 Medullary thyroid carcinoma. Clinical characteristics, treatment, prognostic factors, and a comparison of staging system Cancer 88 1139 1147 1:STN:280: DC%2BD3c7msVelsA%3D%3D 10.1002/(SICI)1097-0142(20000301)88:5<1139::AID- CNCR26>3.0.CO;2-Z 10699905 (Pubitemid 30127676)
3. JWB de Groot IP Kema H Breukelman E van der Veer T Wiggers JTM Plukker BHR Wolffenbuttel TP Links 2006 Biochemical markers in the follow-up of medullary thyroid cancer Thyroid 16 1163 1170 10.1089/thy.2006.16.1163 17123344 (Pubitemid 44864492)
4. Schlumberger M, Pacini F (2003) Medullary thyroid carcinoma. In: Schlumberger M, Pacini F, eds. Thyroid tumors. Paris: Nucleon, 305-335
5. SL Hyer L Vini R A'Hern C Harmer 2000 Medullary thyroid cancer: multivariate analysis of prognostic factors influencing survival Eur J Surg Oncol 26 686 690 1:STN:280:DC%2BD3M%2Fms1Wjsw%3D%3D 10.1053/ejso.2000.0981 11187027
6. S Roman R Lin JA Sosa 2006 Prognosis of medullary thyroid carcinoma. Demographic, clinical, and pathologic predictors of survival in 1252 cases Cancer 107 2134 2142 10.1002/cncr.22244 17019736 (Pubitemid 44665646)
7. SA Hundahl ID Fleming AM Fremgen HR Menck 1998 A National Cancer Data Base report on 53, 856 cases of thyroid carcinoma treated in the U.S., 1985-1995 Cancer 83 2638 2648 1:STN:280:DyaK1M%2FovFylug%3D%3D 10.1002/(SICI)1097- 0142(19981215)83:12<2638::AID-CNCR31>3.0.CO;2-1 9874472 (Pubitemid 29019586)
8. J Barbet L Campion F Kraeber-Bodere JF Chatal 2005 Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling time in patients with medullary thyroid carcinoma J Clin Endocrinol Metab 90 6077 6084 1:CAS:528:DC%2BD2MXht1alt7bJ 10.1210/jc.2005-0044 16091497 (Pubitemid 41606528)
9. Behr TM, Becker W (2005) Imaging of medullary thyroid cancer. In: Biersack HJ, Grünwald F (eds) Thyroid cancer, 2nd edn. Springer Verlag, Berlin, chapter 18:311-333 (ISBN-10 3-540-22309-6)
10. G Pellegriti S Leboulleux E Baudin N Bellon C Scollo J Travagli M Schlumberger 2003 Long-term outcome of medullary thyroid carcinoma in patients with normal postoperative imaging Br J Cancer 88 1537 1542 1:STN:280: DC%2BD3s3ntVyrsg%3D%3D 10.1038/sj.bjc.6600930 12771918 (Pubitemid 36713778)
11. A Machens U Schneyer H Holzhausen H Dralle 2005 Prospects of remission in medullary thyroid carcinoma according to basal calcitonin level J Clin Endocrinol Metab 90 2029 2034 1:CAS:528:DC%2BD2MXjsFWjt7s%3D 10.1210/jc.2004-1836 15634717 (Pubitemid 40586235)
12. EM Rohren TG Turkington RE Coleman 2004 Clinical application of PET in oncology Radiology 231 305 332 10.1148/radiol.2312021185 15044750 (Pubitemid 38552885)
13. ME Juweid BD Cheson 2006 Positron-emission tomography and assessment of cancer therapy N Engl J Med 354 496 507 1:CAS:528:DC%2BD28Xptlajsw%3D%3D 10.1056/NEJMra050276 16452561 (Pubitemid 43200300)
14. BE Hillner BA Siegel D Liu AF Shields IF Gareen L Hanna SH Stine RE Coleman 2008 Impact of positron emission tomography/computed tomography and positron emission tomography (PET) alone on expected management of patients with cancer: initial results from the National Oncologic PET Registry J Clin Oncol 26 2155 22161 10.1200/JCO.2007.14.5631 18362365
15. BE Hillner BA Siegel AF Shields D Liu IF Gareen E Hunt RE Coleman 2009 Relationship between cancer type and impact of PET and PET/CT on intended management: findings of the National Oncologic PET Registry J Nucl Med 49 1928 1935 10.2967/jnumed.108.056713
16. RJ Gillies I Robey RA Gatenby 2008 Causes and consequences of increased glucose metabolism of cancers J Nucl Med 49 Suppl 2 24S 42S 1:CAS:528: DC%2BD1cXotFahurg%3D 10.2967/jnumed.107.047258 18523064 (Pubitemid 351948035)
17. JW de Groot TP Links PL Jager T Kahraman JT Plukker 2004 Impact of 18F-fluoro-2-deoxy-d-glucose positron emission tomography (FGD-PET) in patients with biochemical evidence of recurrent or residual medullary thyroid cancer Ann Surg Oncol 11 786 794 10.1245/ASO.2004.10.015 15289241 (Pubitemid 40486694)
18. S Szakáll O Ésik G Bajzik I Repa G Dabasi I Sinkovics P Ágoston L Trón 2002 18F-FDG PET detection of lymph node metastases in medullary thyroid carcinoma J Nucl Med 43 66 71 11801705
19. M Diehl JH Risse K Brandt-Mainz M Dietlein KH Bohuslavizki P Matheja H Lange J Bredow C Körber F Grünwald 2001 Fluorine-18 fluorodeoxyglucose positron emission tomography in medullary thyroid cancer: results of a multicenter study Eur J Nucl Med 28 1671 1676 1:CAS:528:DC%2BD3MXnvFGhsbc%3D 10.1007/s002590100614 11702109 (Pubitemid 33036110)
20. AL Giraudet D Vanel S Leboulleux A Aupérin C Dromain L Chami NN Tovo J Lumbroso N Lassau G Bonniaud D Hartl J-P Travagli E Baudin M Schlumberger 2007 Imaging medullary thyroid carcinoma with persistent elevated calcitonin levels J Clin Endocrinol Metabol 92 4185 4190 1:CAS:528:DC%2BD2sXhtlartbzP 10.1210/jc.2007-1211 (Pubitemid 350074730)
21. A Oudoux PY Salaun C Bournaud L Campion C Ansquer C Rousseau S Bardet F Borson-Chazot JP Vuillez A Murat E Mirallié J Barbet DM Goldenberg JF Chatal F Kraeber-Bodéré 2007 Sensitivity and prognostic value of positron emission tomography with F-18-fluorodeoxyglucose and sensitivity of immunoscintigraphy in patients with medullary thyroid carcinoma treated with anticarcinoembryonic antigen-targeted radioimmunotherapy J Clin Endocrinol Metab 92 4590 4597 1:CAS:528:DC%2BD1cXmslWhtL0%3D 10.1210/jc.2007-0938 17878252 (Pubitemid 350223431)
22. TWF Yen SE Shapiro RF Gagel SI Sherman JE Lee DB Evans 2003 Medullary thyroid carcinoma: results of a standardized surgical approach in a contemporary series of 80 consecutive patients Surgery 134 890 900 10.1016/S0039-6060(03) 00408-2 14668720 (Pubitemid 38010733)
23. 18F-FDG PET in restaging patients with medullary thyroid carcinoma and elevated calcitonin levels J Nucl Med 48 501 507 1:CAS:528: DC%2BD2sXhtVert7jE 10.2967/jnumed.106.036681 17401085 (Pubitemid 47571403)
24. KP Koopmans JWB de Groot JTM Plukker EGE de Vries IP Kema WJ Sluiter PL Jager TP Links 2008 18F-Dihydroxyphenylalanine PET in patients with biochemical evidence of medullary thyroid cancer: relation to tumor differentiation J Nucl Med 49 524 531 1:CAS:528:DC%2BD1cXltl2gtLs%3D 10.2967/jnumed.107.047720 18375923 (Pubitemid 351520599)
25. AL Giraudet AA Ghulzan A Aupérin S Leboulleux A Chehboun F Troalen C Dromain J Lumbroso E Baudin M Schlumberger 2008 Progression of medullary thyroid carcinoma: assessment with calcitonin and carcinoembryonic antigen doubling times Eur J Endocrinol 158 239 246 1:CAS:528:DC%2BD1cXisFygu7o%3D 10.1530/EJE-07-0667 (Pubitemid 351298542)